The result from this present study supports the several already released reports that the histopathological parameters (gender, metastasis presence, site of metastasis, CEA level, and lymphovascular permeation) of patients may be the best factors for predicting prognosis and survival in colorectal cancer patients, while CCI provides a comprehensive disease burden of the patients. The gene discussed is CEACAM5; the disease is colorectal cancer.